chart daily, page-2296

First 2296 Last

Share
Profile

Follow
Robjhunt

1,473 Posts.

104

17/12/21

21:36

Post #: 58378421
Share

Originally posted by shareman ↑

The reality is:

- at this point we don't know whether BIT225 will even be successful in human trials. Based on drug development reality, BIT225 is more likely to fail than succeed
- In 12 months time, it is likely there will be more competitors on the market. There are hundreds of clinical trials at the moment and even more drugs in early development. Most will likely fail but probability says some will succeed. Pfizer's new drug could well be approved in the very near future.
- Posters here were upramping, just like you are now, over 10 years ago when they were trying to convince HotCopper readers BIT had a cure for Hepatitis C. History shows BIT's hepatitis C program failed. You can see some of these posts in the following link.
https://hotcopper.com.au/threads/bill-gates-mg-foundation-biotron.5631005/page-222?post_id=48007676
- your comment about people still buying brand drugs rather than generics is completely irrelevant. If another painkiller came along that was more effective, safer and still reasonably priced, then paracetamol would indeed be in big trouble and companies would likely stop producing it.

Expand

Look at you go. It's a belief of yours that you think you know everything and can save people from their investment choice.

You are nothing but a WEED!

I think you need another dose because, for some reason, you just linger on.

BIT Price at posting: 9.1¢ Sentiment: None Disclosure: Not Held
6 Upvote

0 Great analysis

Reply

Top Stories

BGL

Bellevue aims for 45% production increase by FY 2028, announces $150M placement

MM1

Geochemical work at Newington picks up gold and copper anomalies for Midas

TRP

Tissue Repairs soars nearly 32% on TGA approval for wound healing gel

Capital raisings wrap: Brainchip, Ovanti, Lake and VHM

PEC

Perpetual sniffs TREOs beyond 4000ppm at Raptor play in Brazil